Funds holding Immuneering Corp
ISIN US45254E1073 · United States
- Fund holders
- 37
- Of which ETFs
- 6 31 other funds
- Value held
- 54.8M $ 9.6M SEK
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 2,845,687 | 14.2M $ | 0.02 % | as of Feb 28, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,623,577 | 8.6M $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 1,290,698 | 6.4M $ | 0.12 % | as of Feb 28, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 812,045 | 4.1M $ | 0.02 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 758,905 | 3.8M $ | 0.02 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 691,472 | 3.6M $ | 0.03 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 624,026 | 3.3M $ | 0.03 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 614,250 | 3.2M $ | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 390,008 | 2.1M $ | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 286,222 | 1.4M $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Nowo Global Fund Nowo Fund Management AB | 191,315 | 9.6M SEK | 1.54 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 132,641 | 699K $ | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 103,064 | 514.3K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 77,976 | 389.1K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Large-Cap Growth Portfolio PACIFIC SELECT FUND | 76,219 | 401.7K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 60,000 | 316.2K $ | 0.37 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 51,854 | 273.3K $ | 0.04 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 49,849 | 262.7K $ | 0.21 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 41,005 | 204.6K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 37,344 | 195.7K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 30,617 | 152.8K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 29,577 | 155.9K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 20,937 | 110.3K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 17,357 | 91.5K $ | 0.04 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 12,686 | 66.9K $ | 0.04 % | as of Mar 31, 2026 ↗ |
| Guardian Large Cap Fundamental Growth VIP Fund Guardian Variable Products Trust | 9,722 | 51.2K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 9,501 | 50.1K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 7,614 | 39.9K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| AVIP Fidelity Institutional AM Equity Growth Portfolio AuguStar Variable Insurance Products Fund Inc | 6,769 | 35.7K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 5,983 | 31.4K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 3,615 | 18K $ | 0.02 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 3,598 | 18.9K $ | as of Apr 30, 2026 ↗ | |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 2,981 | 14.9K $ | 0.02 % | as of Feb 28, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,093 | 5.8K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 500 | 2.6K $ | as of Mar 31, 2026 ↗ | |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 372 | 2K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 282 | 1.5K $ | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Nowo Global Fund Nowo Fund Management AB | 1.54 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 0.37 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.21 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 0.12 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.06 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 0.04 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 0.04 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 0.04 % | as of Mar 31, 2026 ↗ |
| Guardian Large Cap Fundamental Growth VIP Fund Guardian Variable Products Trust | 0.03 % | as of Mar 31, 2026 ↗ |
| Large-Cap Growth Portfolio PACIFIC SELECT FUND | 0.03 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 36 | +2 | 10,730,046 | -16.3 % |
| 2026Q1 | 34 | +7 | 12,827,145 | +184.1 % |
| 2025Q4 | 27 | +14 | 4,514,712 | +221.2 % |
| 2025Q3 | 13 | -5 | 1,405,629 | -24.1 % |
| 2025Q2 | 18 | 0 | 1,851,651 | -6.9 % |
| 2025Q1 | 18 | +1 | 1,988,126 | -1.7 % |
| 2024Q4 | 17 | -48 | 2,023,236 | -34.8 % |
| 2024Q3 | 65 | -28 | 3,104,617 | -23.6 % |
| 2024Q2 | 93 | -10 | 4,062,722 | -34.8 % |
| 2024Q1 | 103 | 0 | 6,229,641 | -4.2 % |
| 2023Q4 | 103 | 6,502,598 |
Institutional managers
94 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 9,697,938 | 51.1M $ | as of Mar 31, 2026 |
| Sanofi | 2,708,559 | 14.3M $ | as of Mar 31, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,288,341 | 12.1M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 1,996,585 | 10.5M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,829,188 | 9.6K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 1,507,258 | 7.9M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,102,712 | 5.8M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 637,944 | 3.4M $ | as of Mar 31, 2026 |
| Occam Crest Management LP | 545,098 | 2.9M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 447,278 | 2.4M $ | as of Mar 31, 2026 |
| Connor, Clark & Lunn Investment Management Ltd. | 400,363 | 2.1M $ | as of Mar 31, 2026 |
| Summit Financial, LLC | 376,749 | 2M $ | as of Mar 31, 2026 |
| UBS Group AG | 376,284 | 2M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 327,655 | 1.7M $ | as of Mar 31, 2026 |
| VANGUARD FIDUCIARY TRUST CO | 322,038 | 1.7M $ | as of Mar 31, 2026 |
| Burkehill Global Management, LP | 300,000 | 1.6M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 296,067 | 1.6M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 268,520 | 1.4M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 244,771 | 1.3M $ | as of Mar 31, 2026 |
| Squarepoint Ops LLC | 226,046 | 1.2M $ | as of Mar 31, 2026 |
| Diametric Capital, LP | 174,897 | 921.7K $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 156,424 | 824.4K $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 150,847 | 795K $ | as of Mar 31, 2026 |
| 683 Capital Management, LLC | 150,697 | 794.2K $ | as of Mar 31, 2026 |
| DCF Advisers, LLC | 141,462 | 745.5K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding Immuneering Corp". https://titelia.com/en/stocks/immuneering-corp-US45254E1073